Fresenius Medical Care (FMS) SEC filings

Fresenius Medical Care's latest annual report is a Form 20-F filed on February 24, 2026 for the period ended December 31, 2025. Its latest Form 6-K report was filed on November 9, 2026. Its latest current report, a Form 8-K, was filed on February 13, 2006 (8.01 Other Events). EDGAR lists 29 filings for it in the last twelve months.

Key facts

Latest annual report
20-F, Feb 24, 2026
Latest 6-K
6-K, Nov 9, 2026
Filings, last 12 months
29
Insider forms, last 12 months
1Forms 3, 4 and 5
13D and 13G, last 12 months
4
SEC central index key
0001333141

Filings as listed by SEC EDGAR at (re-read at most hourly). Source: SEC EDGAR filings for CIK 0001333141. Every form links to its document on sec.gov.

Annual and quarterly reports

Fresenius Medical Care: annual and quarterly reports filed with the SEC
FormFiledPeriod endedDocument
20-FFORM 20-F
20-FFORM 20-F
20-FFORM 20-F
20-FFORM 20-F
20-FFORM 20F
20-FAnnual report of a foreign private issuer
20-FAnnual report of a foreign private issuer
20-F (amended)Annual report of a foreign private issuer
20-FAnnual report of a foreign private issuer
20-FAnnual report of a foreign private issuer
20-FAnnual report of a foreign private issuer
20-FAnnual report of a foreign private issuer
20-FAnnual report of a foreign private issuer
20-FAnnual report of a foreign private issuer
20-FAnnual report of a foreign private issuer
20-F (amended)Annual report of a foreign private issuer

The latest 16 of 27 in EDGAR's recent list. Amended reports are marked. The period is the fiscal year or quarter the report covers.

Reports of a foreign private issuer (Form 6-K)

Fresenius Medical Care: reports on Form 6-K
FormFiledReport dateDocument
6-KFORM 6-K
6-KFORM 6-K
6-KFORM 6-K
6-KFORM 6-K
6-KFORM 6-K
6-KFORM 6-K
6-KFORM 6-K
6-KFORM 6-K
6-KFORM 6-K
6-KFORM 6-K
6-KFORM 6-K
6-KFORM 6-K
6-KFORM 6-K
6-KFORM 6-K
6-KFORM 6-K
6-KFORM 6-K
6-KFORM 6-K
6-KFORM 6-K
6-KFORM 6-K
6-KFORM 6-K

The latest 20 of 420 in EDGAR's recent list. A 6-K carries what the company publishes at home — results, press releases, notices to shareholders.

Current reports (8-K)

Fresenius Medical Care: current reports on Form 8-K and the items each reports
FormFiledEvent dateWhat it reports
8-K12B8.01 Other Events

Item names are the SEC's own, from Form 8-K (a few long ones shortened). The event date is the date of the earliest event reported.

Insider forms (3, 4 and 5)

Fresenius Medical Care: insider forms 3, 4 and 5 filed per month over the last twelve months
MonthForms filed
Nov 20260
Oct 20260
Sep 20260
Aug 20260
Jul 20260
Jun 20260
May 20260
Apr 20260
Mar 20261
Feb 20260
Jan 20260
Dec 20250
Fresenius Medical Care: the latest insider forms
FormFiledTransaction date
3
3

Each form is filed by the insider about their own holding; the trade details are inside the form on sec.gov. Counts include amendments. The current month is counted to date.

Ownership reports (Schedules 13D and 13G)

Fresenius Medical Care: Schedule 13D and 13G beneficial ownership reports
FormFiledEvent date
Schedule 13D (amended)—
Schedule 13D (amended)—
Schedule 13G—
Schedule 13D (amended)—
Schedule 13D (amended)—
Schedule 13D (amended)—
Schedule 13D (amended)—
Schedule 13G (amended)—
Schedule 13G—
Schedule 13G (amended)—
Schedule 13D (amended)—
Schedule 13D (amended)—
Schedule 13G—
Schedule 13G (amended)—
Schedule 13G (amended)—
Schedule 13G—
Schedule 13G (amended)—
Schedule 13G—
Schedule 13G (amended)—
Schedule 13D (amended)—

The latest 20 of 27 in EDGAR's recent list. Filed by the holder, not the company. EDGAR's list names the form and date; who filed it is in the document.

Everything else (125 filings: registrations, prospectuses, Rule 144 notices, correspondence and more)
Fresenius Medical Care: other SEC filings
FormFiledPeriodDocument
11-K
SD—FORM SD
IRANNOTICE—
11-KFORM 11-K
SD—FORM SD
IRANNOTICE—
11-KFORM 11-K
SD—FORM SD
IRANNOTICE—
S-8 POS—
144—Notice of proposed sale
25-NSE—
11-KFORM 11-K
EFFECT—
424B3—Prospectus
425—
425—
CORRESP—
F-4 (amended)—FORM F-4/A
SD—FORM SD
FWP—
425—
UPLOAD—
F-4—FORM F-4
IRANNOTICE—
425—
11-KFORM 11-K
SD—FORM SD
IRANNOTICE—
11-K
SD—Specialized disclosure report
IRANNOTICE—
11-K
SD—Specialized disclosure report
IRANNOTICE—
11-K
SD—Specialized disclosure report
IRANNOTICE—
UPLOAD—
CORRESP—
UPLOAD—
CORRESP—
11-K
UPLOAD—
SD—Specialized disclosure report
F-6 POS—POST EFFECTIVE AMENDMENT NO. 1 TO THE FORM F-6
IRANNOTICE—
11-K
SD—Specialized disclosure report
UPLOAD—
CORRESP—
UPLOAD—
CORRESP—
IRANNOTICE—
11-K
SD—Specialized disclosure report
IRANNOTICE—
11-K
SD—Specialized disclosure report
IRANNOTICE—

The latest 60 of 125 in EDGAR's recent list.

What the forms are

Form 3 — Initial statement of beneficial ownership
An insider's first statement of holdings in the company's equity securities. Insiders are officers, directors and holders of more than 10 percent of a class of its registered equity securities.
Form 4 — Statement of changes in beneficial ownership
An insider's transactions in the company's equity securities, disclosed within two business days of the transaction.
Form 144 — Notice of proposed sale
In the SEC's Forms Index: notice of proposed sale of securities pursuant to Rule 144.
Form 10-K — Annual report
Audited annual financial statements, a discussion of material risk factors, and management's discussion and analysis of the results for the prior fiscal year.
Form 10-Q — Quarterly report
Unaudited quarterly financial statements, updates on material risks, and management's discussion and analysis of the results for the prior fiscal quarter.
Form 8-K — Current report
Discloses material events or information the company chooses or is required to make public before its next scheduled quarterly or annual report. Each report lists the items it covers.
Form 20-F — Annual report of a foreign private issuer
Audited financial statements of the foreign private issuer and a discussion of its financial results; the same form is used to register a class of securities.
Form 6-K — Report of a foreign private issuer
Filed with press releases, communications to security holders, and disclosures the company's home country requires it to make to security holders.
Schedule 13D — Schedule 13D beneficial ownership report
Filed when a party acquires more than five percent of a class of the company's registered voting securities; also used to disclose later changes to the holding.
Schedule 13G — Schedule 13G beneficial ownership report
Filed when a party acquires more than five percent of a class of the company's registered voting securities as a passive investment.
Form S-8 — Registration statement for employee plans
In the SEC's Forms Index: registration statement under the Securities Act of 1933 for securities to be offered to employees under certain plans.
Form 424B — Prospectus
A document disclosing information about the company and an offering; it typically makes up a large part of the registration statement.
Form SD — Specialized disclosure report
In the SEC's Forms Index: Specialized Disclosure Report.

From the SEC's own descriptions: SEC, Using EDGAR to Research Investments; SEC, Forms Index; SEC, Form 8-K and its items (PDF).

Questions and answers

Where is Fresenius Medical Care's latest annual report (20-F)?

Fresenius Medical Care filed its latest Form 20-F with the SEC on February 24, 2026 for the period ended December 31, 2025. The table of annual and quarterly reports on this page links to the document on sec.gov.

What has Fresenius Medical Care reported on Form 8-K recently?

Its latest 8-K was filed on February 13, 2006 (8.01 Other Events). An 8-K discloses material events before the next quarterly or annual report.

How many insider filings (Forms 3, 4 and 5) were there for FMS in the last year?

1 insider form in the twelve months to November 18, 2026, the latest a Form 3 filed on March 18, 2026. Officers, directors and holders of more than 10 percent of a class of the company's registered equity securities must disclose their holdings and transactions; a Form 4 is due within two business days of a trade.

Has anyone reported owning more than 5% of Fresenius Medical Care?

EDGAR lists 4 Schedule 13D or 13G filings about Fresenius Medical Care in the last twelve months, the latest on November 13, 2026. These are filed by a party that acquires more than five percent of a class of the company's voting securities; 13G is for passive investors.

Cite this page

Funkfolio, “Fresenius Medical Care (FMS) SEC filings: 20-F and 6-K”, data as of 18 November 2026. https://funkfolio.com/stock/FMS/filings

Underlying data: SEC EDGAR submissions (data.sec.gov).